Background-The use of coronary artery bypass grafting (CABG) surgery in China is growing, but little is known about hospital-level performance. We sought to characterize the variation in performance across hospitals participating in a national registry in China. Methods and Results-The study sample was drawn from the Chinese Cardiac Surgery Registry, a national multicenter database that includes 43 hospitals across 13 provinces and 4 direct-controlled municipalities in China. We assessed consecutive patients undergoing isolated CABG surgery during the period of January 1, 2007, through December 31, 2008. Hierarchical generalized linear models were used to estimate hospital-level risk-standardized in-hospital all-cause mortality rates (RSMR) and major complication rates (RSMCR), which included death, myocardial infarction, reoperation for bleeding, mediastinal infection, stroke, reintubation, and renal failure. Among 8739 patients who underwent isolated CABG surgery, the mean age was 62.2 years (SDϭ9.2), and 78% were male. Observed in-hospital mortality and complication rates were 2.2% (95% confidence interval [CI], 1.9 -2.5%) and 6.6% (95% CI, 6.1-7.1%), respectively. The mean RSMR was 1.9% (SDϭ1.1), with a range of 0.7-5.8%, and the mean RSMCR was 6.4% (SDϭ1.5), with a range of 3.8 -10.1%. The odds of dying and the odds of having a complication after CABG surgery at a hospital 1 SD below the average relative to a hospital 1 SD above the average were 2.06 (95% CI, 1.40 -3.04) and 1.53 (95% CI, 1.31-1.79), respectively. The Eastern region had the lowest RSMR and RSMCR (1.6% and 5.8%, respectively), whereas the Central region had the highest RSMR (2.5%) and the Southern region had the highest RSMCR (7.7%). Conclusions-Mortality and complication rates after CABG surgery in the Chinese Cardiac Surgery Registry are generally low but vary by hospital and region within China. These results suggest that there are opportunities to improve outcomes in some CABG facilities. (Circ Cardiovasc Qual Outcomes. 2012;5:214-221.)
surgery in China. To address this issue we used the Chinese Cardiac Surgery Registry (CCSR) to evaluate CABG outcomes in China. The CCSR, funded by the Chinese government in 2004, is the largest CABG registry in China.
WHAT IS KNOWN
• In the United States, variation in patient outcomes after CABG has been documented.
WHAT THE STUDY ADDS
• The current study can reveal whether Chinese hospitals are achieving good and uniform results, and if not, may provide insights in how to improve care. • Our findings can inform practitioners and policymakers about what is being achieved and what can be done better. • The mortality and complication rates from the 43 centers can be used as benchmarks to evaluate other Chinese CABG centers' performance. • The ability and willingness to measure performance is an important milestone toward integrating improvement into the Chinese health care system.
Methods

Data Source
The study sample was drawn from the CCSR, a multicenter registry, launched in 2004, with the primary purpose of evaluating surgical outcomes in patients undergoing cardiac surgery. The registry is overseen by a steering committee that includes cardiac surgeons and researchers from Fuwai Hospital, a hospital affiliated with the Peking Union Medical College in Beijing, China. Funding for the registry comes from the Chinese government as part of the National Science and Technology Pillar Program during the 11th 5-year plan period. At the beginning of the registry, a telephone survey sponsored by CCSR committee was conducted to obtain annual surgery volume information of each cardiac center to decide which centers should be included. The center address list was provided by Chinese Society for Thoracic and Cardiovascular Surgery. According to the results of CCSR survey, there were 601 hospitals rendering services in the field of cardiac surgery, and 268 had an annual cardiac surgery volume of Ͼ100. These 268 centers were clustered in 25 provinces and 4 directly controlled municipalities (of which the administrative ranking is equal to a province). The invitation to take part in the registry was limited to these 268 centers. A total of 43 centers from 13 provinces and 4 directly controlled municipalities agreed to participate in the CCSR. Patients were evenly distributed among the 13 provinces and 4 directly controlled municipalities representing various stages of economic development. Based on the survey, we estimate that the registry includes about 25% of the total isolated CABG surgeries performed in China. The participating institutions vary by geographic and administrative boundaries in 13 provinces and 4 direct controlled municipalities ( Figure 1 ).
Each participating institution received detailed information on data collection requirements and definitions of variables. A standardized case report form (CRF) containing demographic, preoperative risk factors, operative information, postoperative treatment course, and surgical outcomes was used.
Training for data collection was conducted at each site by the Coordinating Center. All the data were collected by trained clinical research staff including research nurses or residents at local sites. Every site completed a CRF for each hospitalization. The CRFs were then submitted to the data processing center of Chinese Cardiac Surgery Registry and double entered into the database by trained technicians. Two reviewers from the data processing center abstracted a random sample of 5-10% of medical records through on-site auditing at a 6-month interval. The data submitted by the hospitals were compared with information in the medical records. When a disagreement occurred, a physician adjudicated the disagreement to determine the correct final value.
Study Sample
The study focused on CCSR patients Ն17 years old who underwent isolated CABG surgery from January 1, 2007, through December 31, 2008, either off-pump or on-pump. Although not standard, our prespecified inclusion criteria was age 17 years or older because, although rare in children, the precursors of atherosclerotic cardiovascular diseases are present in the young. 4
Patient and Hospital Characteristics
Several patient risk factors were collected and used for risk adjustment (Table 1) , including demographics, coronary anatomy, comorbidities, and triage status. We used estimated glomerular filtration rate (eGFR, mL/min per 1.73 m 2 ) 5 to measure renal function by the following equation: 186ϫ(serum creatinine level [mg/dL]) Ϫ1.154 ϫ(age [y]) Ϫ0.203 . We also used the European System for Cardiac Operative Risk Evaluation (EuroSCORE), which is a widely adopted risk model including 19 variables, 6 for risk adjustment.
Key hospital characteristics include teaching status, cardiovascular specialty status, ownership (public versus private), and military affiliation. Cardiovascular specialty hospitals are hospitals in which the faculty is dedicated exclusively to cardiovascular disease support and treatment. Teaching hospitals are those affiliated with medical schools or postgraduate training programs. Hospitals were also 
Outcome Measures
The primary hospital-level outcomes were in-hospital riskstandardized mortality (RSMR) and risk-standardized major complication rate (RSMCR). A major complication was defined as the occurrence of any of the following events: all-cause death, myocardial infarction, reoperation for bleeding, mediastinal infection, stroke, reintubation, and renal failure. Myocardial infarction was those newly occurred postoperatively and was defined as any one of the following: documented in the medical record or ECGdocumented Q waves that are 0.03 seconds in width and/or one-third or greater of the total QRS complex in 2 or more contiguous leads. Reoperation for bleeding was defined as chest tube drainage Ն200 mL/h for at least 3 hours. Mediastinal infection was defined as a documented debridement within the medical record. Stroke was defined as central neurological deficit persisting Ͼ72 hours (ie, extremity weakness or loss of motion, loss of consciousness, loss of speech, visual field cuts). Renal failure was defined as increase of serum creatinine to Ͼ2 mg/dL, or 2ϫ most recent preoperative creatinine level, or a new requirement for dialysis postoperatively. Additionally, we assessed the length of stay, defined as the difference between discharge and admission dates plus 1 day.
Statistical Analysis
We conducted bivariate analyses to compare the differences in patient characteristics across regions, using 2 tests for categorical variables and t tests for continuous variables.
A few variables had missing values in the CCSR, with patientlevel data completion ranging from 97-100% (see online-only Data Supplement Table I ). When there were missing values, we created an additional binary variable that assigned a value of 1 if missing and 0 otherwise. We then set the missing values with the median of observed values for a continuous variable with missing values and added an additional level that indicated a variable has missing values for a categorical or binary variable. We included the additional binary variable and its corresponding variable in the model. This method of modeling missing data assumes data are missing at random and permits inclusion of all available cases, although it is not as efficient as multiple imputation procedures.
Using hierarchical logistic regression modeling, 7 we estimated a random intercept risk model relating the log-odds of in-hospital BMI indicates body mass index; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease.
*"Territory" refers to the 3 coronary vessel trees (left anterior descending artery, circumflex artery, and right coronary artery); "diseased territory" refers to those territories with stenosis Ͼ70%.
† Continuous variables were analyzed by a t test; categorical variables were analyzed by the 2 test. §Variables in risk adjustment.
mortality to patient risk factors for the study sample. The candidate variables used for risk adjustment were selected on the basis of clinical knowledge and previous studies (footnoted in Table 1 ). The model provides information to compute standardized hospitalspecific estimates as well as quantitative summaries of betweenhospital variation after adjusting for case mix. Using the regression coefficients from the risk model, we calculated a standardized mortality ratio (SMR), defined as hospital-specific mortality divided by the hospital expected mortality 7 for each hospital included in the study sample. We then multiplied the SMR by the average observed mortality rate of the 43 hospitals to obtain an RSMR for each hospital. We used the nonparametric bootstrapping method to generate 1000 samples with replacement to estimate a 95% confident interval (CI) for each hospital RSMR and to determine which hospitals had RSMRs that were lower than the average mortality rate of the 43 hospitals. 8 We classified hospitals into 3 mutually exclusive groups: (1) better, if the upper limit of a hospital's 95% CI is less than the average mortality, (2) worse, if the lower limit of a hospital's 95% CI is higher than the average mortality, and (3) as-expected, if a hospital's 95% CI overlaps with the average. Using bootstrapping samples, we also calculated the probability of a RSMR below than the average for each hospital. We used the same approach to calculate a standardized complication ratio, RSMCR, 95% CI of RSMCR, and the probability of RSMCR below than the average for each hospital and classified them into the better, worse, and as-expected groups. We estimated between-hospital variations in mortality and complication rates to quantify differences in hospital quality of care for CABG. We calculated the odds of dying or having a major complication if a patient was treated at a hospital 1 SD above the average of mortality or complication rate of 43 hospitals relative to the odds of dying or having a major complication if a patient was treated at a hospital 1 SD below the average. We classified hospitals into regions based on their locations and calculated the regionspecific aggregated weighted RSMRs and RSMCRs. All statistical testing was 2-sided, at a significance level of 0.05, and all analyses using SAS version 9.1.3 (SAS Institute Inc, Cary, NC) and estimated the hierarchical models using the GLIMMIX procedure in SAS.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written. The Fuwai Hospital Institutional Review Board has reviewed and approved the study.
Results
Sample
Over the study period, a total of 9844 consecutive patients underwent CABG surgery across 43 centers. Of the 9844 patients, 8739 (88.8%) underwent isolated CABG and were included in the study (Figure 2 ). The mean age was 62.2Ϯ9.2 years and 78.4% were male. On-pump CABG accounted for 40.9% of all the procedures in the current study. Patient characteristics varied greatly by region ( 
Overall RSMR and RSMCR
The observed in-hospital mortality and complication rates were 2.2% (95% CI, 1.9 -2.5) and 6.6% (95% CI, 6.1-7.1), respectively ( Table 3 ). The volume-weighted correlation between RSMR and RSMCR (with death) was 0.58 (PϽ0.001) and the volume-weighted correlation between RSMR and RSMCR without death was 0.27 (PϽ0.001). The SMR ranged from 0.33-2.70, and the standardized complication ratio ranged from 0.57-1.54. The mean (SD) RSMR was 1.9% (1.1) and varied from 0.7-5.8%; mean (SD) RSMCR was 6.4% (1.5) and ranged from 3.8 -10.1% (see online-only Data Supplement Table II for details of the risk-adjusted model). Among these 43 hospitals, there was 1 hospital with an RSMR statistically lower than average (RSMRϭ0.7%) and 4 hospitals with RSMRs statistically higher than average (RSMRs between 4.2-5.8%) (Figure 3) . Similarly, there were 2 hospitals with RSMCRs statistically lower than average (RSMCRs of 4.3% and 4.6%) and 1 hospital with an RSMCR statistically higher than average (RSMCRϭ10.1%) (Figure 4) . The risk-standardized odds of mortality and odds of a major complication when undergoing isolated CABG at a hospital 1 SD below average relative to a hospital 1 SD above average were 2.06 (95% CI, 1.40 -3.04) and 1.53 (95% CI, 1.31-1.79), respectively. The overall median (25th, 75th percentiles) length of stay (LOS) was 22 days (16 -30), excluding 50 patients who had LOS Ͼ100 days.
Regional Variation
Variation in outcomes was observed across regions when hospitals were grouped into Eastern China, Northern China, Southern China, and Central China regions. The means (SD) RSMRs of above regions were East: 1.6% (0.6), North: 2.0% (1.1), South: 1.7% (1.8), and Central: 2.5% (1.8) (PϽ0.001), respectively; the means (SD) RSMCR was East: 5.8% (1.5), North: 6.5% (1.5), South: 7.7% (0.2), and Central: 6.5% (1.8) (PϽ0.001), respectively (Table 3 ).
Discussion
In this contemporary report of CABG surgery in China, we assessed in-hospital mortality and complication rates and demonstrated modest differences among sites, with some sites performing significantly better and worse than the overall average. Our findings provide evidence-based infor- mation about the performance of CABG among these hospitals and indicate the sites where there may be opportunities for improvement. To the best of our knowledge, this is the first study to report CABG outcomes in China. Worldwide, despite increased worsening risk profiles, the short-term outcomes after CABG continue to improve. Research using the he STS database from the United States has demonstrated that the observed operative mortality for isolated CABG decreased from 3.9% in 1990 to 2.3% in 2006. 9, 10 Similar observations have been reported using region or nationwide databases from other countries. The observed mortality for isolated CABG was around 2.0% in northwest England 11 and in the database of Australian Society of Cardiac and Thoracic Surgeons (ASCTS). 12 In the CCSR database involving 43 leading heart centers around China, the observed mortality for isolated CABG was 2.2%, suggesting that the elite Chinese heart centers have the potential to achieve a comparable level of performance as measured by mortality.
In China, variations in outcomes may also exist and depend on site of treatment. 13 China has undergone rapid advances in technological capabilities over the past 30 years, and it is uncertain if they are achieving results at their best centers that are comparable to Western countries. Cardiac surgery is an ideal place to start measuring performance and outcomes in China because of the history of performance measurement in the field and the existence of a robust registry of a large number of Chinese centers that was based, in part, on the US Society of Thoracic Surgeons' example. 10 An interesting finding from the current study is that hospital's mortality performance and hospital's complications performance were correlated but did vary. Prior studies have suggested that factors related to complications may not be the same as those associated with mortality. 14, 15 Building on the previous evidence, a study involving 84 730 patients from the American College of Surgeons National Surgical Quality Improvement Program further suggested that successful management of complications may be equally important as avoiding complications after surgery. 16 Therefore, hospital rankings according to single performance measures should be cautious and multiple measures are needed to better characterize hospital performance. 17 Our study has limitations that warrant discussion. First, the 43 centers included in our study are large CABG centers in China and thus are not representative of the CABG centers that did not submit data to CCSR. Nevertheless, most registries studies have limitations with regard to representativeness. The CCSR registry represents a diverse group of hospitals and a high percentage of provinces with large cardiac surgery centers and representing various stages of economic development were included. All the participating centers are prominent surgical centers, and this report provides a perspective on their performance. Therefore, we are confident that we capture the variation among sophisticated cardiac surgery centers in China. Second, the data were collected at each center, instead of centrally collected. However, we randomly checked and audited the data for accuracy, and we had a system in place to centralize and standardize the data collection process. Third, in this study we assessed in-hospital mortality. It would have been preferable to assess a standardized period of time, such as 30 days, but this information was not available in the CCSR. However, it should be noted that the median length of stay was 22 days, mitigating some concerns about not having longer follow-up to 30 days. Finally, there may be unmeasured case mix differences between the participating centers. Because our data were based on medical records, the unmeasured casemix effects seem to be small.
Outcome measurement provides key information about performance and is necessary to creating an accountable health care system dedicated to continual improvement. 17 A first step is assembling the data that allows for an assessment of performance and an evaluation of variation among centers. 18 In the United States, several states, including New York, Massachusetts, New Jersey, California, and Pennsylvania, have publicly reported hospital-level outcomes for patients undergoing CABG. This transparency of performance and commitment to identifying and addressing differences is a sign of a high functioning system. The effort to characterize performance is not intended to stigmatize programs with worse performance but to illuminate the differences and to use the information as a basis for quality improvement. 19 In addition, the identification of hospitals with better than average performance provides the opportunity to learn what processes may be responsible for their success. 20 -22 In China, measuring hospital performance is gaining importance among Chinese health care leaders. Although this study reported mortality and complication rates across only 43 CABG centers, going forward, the CCSR aims to measure and report all large CABG centers in China.
Conclusions
This study represents a new era of accountability among hospitals performing CABG surgery in China. For the first time, Chinese hospitals are collecting data to evaluate their performance and are publishing the results. The findings indicate that the large CABG centers in China are achieving results that are similar to the United States. Moreover, like the United States, China also has variation in performance among CABG sites. Our findings can inform practitioners and policymakers about what is being achieved and what can be done better. The mortality and complication rates from the 43 centers can be used as benchmarks to evaluate other CABG centers' performance. The ability and willingness to measure performance is an important milestone toward integrating improvement into the Chinese health care system.
